ENVERIC BIOSCIENCES, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ENVERIC BIOSCIENCES, INC. (ENVB) had Lessee, Operating Lease, Liability, to be Paid, Year One of $64.23 thousand as of 2022-12-31, per its 10-K/A filed 2023-06-09.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2023-06-09
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $64.23K.
- 2020-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $192.47K.
- 2020-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $192.47K.
- 2020-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $156.87K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2022-12-31 | $64.23K 10-K/A · filed 2023-06-09 | |
| 2020-09-30 | $192.47K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $192.47K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $156.87K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $136.35K 10-K/A · filed 2020-08-12 | $265.26K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |